These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 24899129

  • 1. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms.
    Abaza MS, Bahman AM, Al-Attiyah RJ.
    Int J Mol Med; 2014 Aug; 34(2):513-32. PubMed ID: 24899129
    [Abstract] [Full Text] [Related]

  • 2. Superior antimitogenic and chemosensitization activities of the combination treatment of the histone deacetylase inhibitor apicidin and proteasome inhibitors on human colorectal cancer cells.
    Abaza MS, Bahman AM, Al-Attiyah R.
    Int J Oncol; 2014 Jan; 44(1):105-28. PubMed ID: 24146045
    [Abstract] [Full Text] [Related]

  • 3. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.
    Abaza MS, Bahman AM, Al-Attiyah RJ, Kollamparambil AM.
    Tumour Biol; 2012 Dec; 33(6):1951-72. PubMed ID: 23011889
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X, Zhu Y, He H, Lou L, Ye W, Chen Y, Wang J.
    Biochem Biophys Res Commun; 2013 Jun 28; 436(2):259-64. PubMed ID: 23726914
    [Abstract] [Full Text] [Related]

  • 6. Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.
    Stamatopoulos B, Meuleman N, De Bruyn C, Mineur P, Martiat P, Bron D, Lagneaux L.
    Leukemia; 2009 Dec 28; 23(12):2281-9. PubMed ID: 19710697
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
    Feng J, Cen J, Li J, Zhao R, Zhu C, Wang Z, Xie J, Tang W.
    Cell Adh Migr; 2015 Dec 28; 9(6):495-501. PubMed ID: 26632346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P, Tagliaferri P, Di Martino MT, Calimeri T, Amodio N, Bulotta A, Ventura M, Eramo PO, Viscomi C, Arbitrio M, Rossi M, Caraglia M, Munshi NC, Anderson KC, Tassone P.
    Br J Haematol; 2008 Nov 28; 143(4):520-31. PubMed ID: 18986388
    [Abstract] [Full Text] [Related]

  • 10. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
    Yoon JY, Ishdorj G, Graham BA, Johnston JB, Gibson SB.
    Apoptosis; 2014 Jan 28; 19(1):191-200. PubMed ID: 24057147
    [Abstract] [Full Text] [Related]

  • 11. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
    Kircher B, Schumacher P, Petzer A, Hoflehner E, Haun M, Wolf AM, Nachbaur D, Gastl G.
    Eur J Haematol; 2009 Jul 28; 83(1):48-56. PubMed ID: 19226363
    [Abstract] [Full Text] [Related]

  • 12. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T, Hrabeta J, Poljakova J, Eckschlager T, Stiborova M.
    Neuro Endocrinol Lett; 2012 Jul 28; 33 Suppl 3():16-24. PubMed ID: 23353839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.
    Cha HY, Lee BS, Kang S, Shin YS, Chang JW, Sung ES, Kim YS, Choi JW, Kim JH, Kim CH.
    Ann Surg Oncol; 2013 Dec 28; 20 Suppl 3():S716-24. PubMed ID: 23982257
    [Abstract] [Full Text] [Related]

  • 16. Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cells.
    Gavrilov V, Lavrenkov K, Ariad S, Shany S.
    Anticancer Res; 2014 Nov 28; 34(11):6565-72. PubMed ID: 25368259
    [Abstract] [Full Text] [Related]

  • 17. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep 28; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.
    Tesei A, Brigliadori G, Carloni S, Fabbri F, Ulivi P, Arienti C, Sparatore A, Del Soldato P, Pasini A, Amadori D, Silvestrini R, Zoli W.
    J Cell Physiol; 2012 Oct 28; 227(10):3389-96. PubMed ID: 22212895
    [Abstract] [Full Text] [Related]

  • 20. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA.
    Prostate; 2007 Jul 01; 67(10):1099-110. PubMed ID: 17477369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.